OnTheIssuesLogo

Tom Price on Drugs

Republican Representative (GA-6)

 


Criticized for comments on opioid addiction treatment

Price's comments suggesting opioid-type medication to treat opioid addiction isn't very effective prompted hundreds of experts to urge him to unequivocally support the treatment. Price's comments prompted more than 600 practitioners and researchers to sign a letter asking Price to "set the record straight." "The perception that persons receiving long-term therapy with medications--especially with buprenorphine and methadone--are not actually in recovery is widespread but grossly inaccurate."
Source: PolitiFact.com on 2019-20 Georgia 2-year Senate race , May 26, 2017

Opposes needle exchange programs

Dr. Price voted to block U.S. funding for needle exchange programs in 2009, several years into his now-12-year stint representing Georgia's sixth Congressional District in the U.S. House of Representatives. He also voted in 2007 to prevent the District of Columbia from using its own, nonfederal funds on needle exchange programs.
Source: Science Magazine on 2019-20 Georgia 2-year Senate race , Dec 2, 2016

Co-signs support letter to free states to act on marijuana

"The legal status of cannabis in the United States is in disarray. It is incumbent on Congress to clarify these issues and reform our federal laws," Collins, the ranking minority member on the House Judiciary Committee, wrote to chairman Jerrold Nadler, with Matt Gaetz, who co-signed the letter. The Republican lawmakers are endorsing the Strengthening the Tenth Amendment Through Entrusting States Act, a bill to shield state cannabis laws from federal intervention.
Source: Forbes Magazine on 2019-20 Georgia 2-year Senate race , Aug 25, 2014

Voted NO on more funding for Mexico to fight drugs.

Congressional Summary:Merida Initiative to Combat Illicit Narcotics and Reduce Organized Crime Authorization Act:
    Provide assistance for Mexico for:
  1. counternarcotics and countertrafficking;
  2. port & airport security to assist in controlling the Mexico-US and Mexico-Central America borders;
  3. intelligence gathering operational technology; and
  4. public security and law enforcement, including assistance to the National Council Against Addiction (CONADIC).

Proponent's argument to vote Yes:Rep. HOWARD BERMAN (D, CA-28): The drug crisis facing the US remains a top national security threat. This bill represents a new partnership with Mexico and Central American countries to face the immediate security threat of drug gangs, and help these neighbors build the capacity of their law enforcement agencies.

Opponent's argument to vote No:Rep. MICHAEL McCAUL (R, TX-10): We need a strategy on this side of the border: a two-pronged Approach; a comprehensive strategy that deals not only with the Mexican side but with the US side. And for too long, our border sheriffs and our Border Patrol agents have been outmanned and outgunned. And if we are going to provide assistance to Mexico, it seems to me we ought to be providing assistance to our men and women on our side fighting this war every day.

Rep. TED POE (R, TX-2): I am concerned about drugs and violence on the border, but I am also concerned about corruption. In order to gain control of access corridors in the US, drug cartels are hiring hit men from an elite force in Mexico's military. This group is known as the "Zetas." Some of the Zetas are military deserters that may have been trained in the US. $1 billion in this bill would go to Mexico. And Mexico in its arrogance objects to any conditions we want to put on this money. The administration can offer us no assurance that our equipment and training won't be used against us and neither can Mexico.

Reference: Merida Initiative; Bill HR.6028 ; vote number 2008-H393 on Jun 10, 2008

Rated -10 by NORML, indicating a "hard-on-drugs" stance.

Price scores -10 by the NORML on drug reform

OnTheIssues.org interprets the 2006 NORML scores as follows:

About NORML (from their website, www.norml.org):

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Source: NORML website 06n-NORML on Dec 31, 2006

Rated 0% by NORML, indicating an anti-legalization stance.

Price scores 0% National Organization for the Reform of Marijuana Law

Scoring system for 2014: Ranges from 0% (opposes all forms of marijuana decriminalization) to 75% (supports marijuana decriminalization and legalization).

About NORML (from their website, www.norml.org):

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Source: NORML rating on incumbents of 113th Congress 14_NORML on Jan 1, 2014

Rated D by NORML, indicating a "hard-on-drugs" stance.

Price scores D by the NORML on drug reform

OnTheIssues.org interprets the 2016 NORML scores as follows:

About NORML (from their website, www.norml.org):

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Source: NORML website 16_NORML on Nov 8, 2016

Other candidates on Drugs: Tom Price on other issues:
GA Gubernatorial:
Andrew Hunt
Brian Kemp
Casey Cagle
Hunter Hill
Jason Carter
Keisha Lance Bottoms
Nathan Deal
Sonny Perdue
Stacey Abrams
GA Senatorial:
Allen Buckley
David Perdue
Derrick Grayson
Doug Collins
Jason Carter
Jim Barksdale
John Barrow
Johnny Isakson
Jon Ossoff
Kelly Loeffler
Matt Lieberman
Ted Terry
Teresa Tomlinson

GA politicians
GA Archives
Senate races 2019-20:
AK: Sullivan(R,incumbent) vs.Gross(I)
AL: Jones(D,incumbent) vs.Sessions(R) vs.Moore(R) vs.Mooney(R) vs.Rogers(D) vs.Tuberville(R) vs.Byrne(R) vs.Merrill(R)
AR: Cotton(R,incumbent) vs.Mahony(D) vs.Whitfield(I) vs.Harrington(L)
AZ: McSally(R,incumbent) vs.Kelly(D)
CO: Gardner(R,incumbent) vs.Hickenlooper(D) vs.Madden(D) vs.Baer(D) vs.Walsh(D) vs.Johnston(D) vs.Romanoff(D) vs.Burnes(D) vs.Williams(D)
DE: Coons(D,incumbent) vs.Scarane(D)
GA-2: Isakson(R,resigned) Loeffler(R,appointed) vs.Lieberman(D) vs.Collins(R) vs.Carter(D)
GA-6: Perdue(R,incumbent) vs.Tomlinson(D) vs.Ossoff(D) vs.Terry(D)
IA: Ernst(R,incumbent) vs.Graham(D) vs.Mauro(D) vs.Greenfield(D)
ID: Risch(R,incumbent) vs.Harris(D) vs.Jordan(D)
IL: Durbin(D,incumbent) vs.Curran(R) vs.Stava-Murray(D)
KS: Roberts(R,retiring) vs.LaTurner(R) vs.Wagle(R) vs.Kobach(R) vs.Bollier(D) vs.Lindstrom(R) vs.Grissom(D) vs.Marshall(R)
KY: McConnell(R,incumbent) vs.McGrath(D) vs.Morgan(R) vs.Cox(D) vs.Tobin(D) vs.Booker(D)
LA: Cassidy(R,incumbent) vs.Pierce(D)

MA: Markey(D,incumbent) vs.Liss-Riordan(D) vs.Ayyadurai(R) vs.Kennedy(D)
ME: Collins(R,incumbent) vs.Sweet(D) vs.Gideon(D) vs.Rice(D)
MI: Peters(D,incumbent) vs.James(R)
MN: Smith(D,incumbent) vs.Carlson(D) vs.Lewis(R) vs.Overby(G)
MS: Hyde-Smith(R,incumbent) vs.Espy(D) vs.Bohren(D)
MT: Daines(R,incumbent) vs.Bullock(D) vs.Collins(D) vs.Mues(D) vs.Driscoll(R) vs.Giese(L)
NC: Tillis(R,incumbent) vs.E.Smith(D) vs.S.Smith(R) vs.Cunningham(D) vs.Tucker(R) vs.Mansfield(D)
NE: Sasse(R,incumbent) vs.Janicek(R)
NH: Shaheen(D,incumbent) vs.Martin(D) vs.Bolduc(R) vs.O'Brien(f)
NJ: Booker(D,incumbent) vs.Singh(R) vs.Meissner(R)
NM: Udall(D,retiring) vs.Clarkson(R) vs.Oliver(D) vs.Lujan(D) vs.Rich(R)
OK: Inhofe(R,incumbent) vs.Workman(D)
OR: Merkley(D,incumbent) vs.Romero(R) vs.Perkins(R)
RI: Reed(D,incumbent) vs.Waters(R)
SC: Graham(R,incumbent) vs.Tinubu(D) vs.Harrison(D)
SD: Rounds(R,incumbent) vs.Borglum(R) vs.Ahlers(D)
TN: Alexander(R,incumbent) vs.Sethi(R) vs.Mackler(D) vs.Hagerty(R)
TX: Cornyn(R,incumbent) vs.Hegar(D) vs.Hernandez(D) vs.Bell(D) vs.Ramirez(D) vs.West(D)
VA: Warner(D,incumbent) vs.Taylor(R) vs.Gade(R)
WV: Capito(R,incumbent) vs.Swearengin(D) vs.Ojeda(D)
WY: Enzi(R,incumbent) vs.Ludwig(D) vs.Lummis(R)
Abortion
Budget/Economy
Civil Rights
Corporations
Crime
Drugs
Education
Energy/Oil
Environment
Families
Foreign Policy
Free Trade
Govt. Reform
Gun Control
Health Care
Homeland Security
Immigration
Jobs
Principles
Social Security
Tax Reform
Technology
War/Peace
Welfare

Other Senators
Senate Votes (analysis)
Bill Sponsorships
Affiliations
Policy Reports
Group Ratings

Contact info:
Fax Number:
202-225-4656
Official Website
Phone number:
(202) 225-4501
Search for...





Page last updated: Jul 18, 2020